• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Trending

Ticker Change

From 2025.11.20 (EST) changed to GNFTY

Event Tracking

Dec10
Genfit SA reports preliminary results of GNS561 and MEK inhibitor combination for KRAS-mutated cholangiocarcinoma Phase 1b trial
17:00
Nov10
GENFIT Partners with EVerZom to Enhance ACLF Research Using Exosome-based Regenerative Technology
07:07
Genfit SA presents preclinical data of G1090N for ACLF treatment
06:30
Sep23
Genfit released FY2025 Semi-Annual earnings on September 22 (EST), actual revenue USD 40.18 M (forecast USD 115.36 M), actual EPS USD -0.2253 (forecast USD -0.1521)
03:00
Genfit released FY2025 Q1 earnings on September 22 (EST), actual revenue USD 19.23 M (forecast USD 143.75 M), actual EPS USD -0.1082
03:00
Genfit released FY2025 Q2 earnings on September 22 (EST), actual revenue USD 20.8 M (forecast USD 33.61 M), actual EPS USD -0.117
03:00

Schedules & Filings

Schedules
Filings
Nov20
Ticker Change(EST)

From 11.20 changed to GNFTY

Sep22
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 20.8 M, Net Income -5.827 M, EPS -0.117

Apr24
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 4.988 M, Net Income -14.98 M, EPS -0.3183

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MGRT
13.050
+143.93%
+7.700
PCSA
6.680
+122.30%
+3.675
YCBD
2.270
+58.74%
+0.840
ATPC
0.1408
+56.44%
+0.051
VYNE
0.6000
+48.99%
+0.197
ANDG
23.500
+46.88%
+7.500
ISPO
4.170
+46.83%
+1.330
MDLN
41.000
+41.38%
+12.000
CGTL
1.250
+31.30%
+0.298
GLIBR
8.490
+29.03%
+1.910
View More